Status:
UNKNOWN
Use of Non-invasive Optical Analysis in Neurosurgery
Lead Sponsor:
Imperial College London
Conditions:
Brain Tumour
Glioma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The present study aims to investigate the potential application of multispectral analysis, hyperspectral imaging, and fluorescence during neuro-oncological procedures, specifically during brain tumour...
Detailed Description
Surgical resection of brain tumours remains a challenge. While the center of a tumour is easily resectable, its margins are often fading into normal brain, and therefore quite difficult to identify. M...
Eligibility Criteria
Inclusion
- Candidates for surgery due to a confirmed clinical and radiological diagnosis of cranial intrinsic or extrinsic tumour - any histological diagnosis confirming neuro-oncological disease, including primary and secondary disease
- Agreed to take part to the present research protocol and signed proper informed consent form
Exclusion
- Suspected differential diagnosis of pathological condition affecting central nervous system other than neuro-oncological disease - including demyelinating diseases, infections, brain traumas / haematomas, vascular or auto-immune diseases
- Patients not capable to give consent - not in condition of understanding, processing and retaining information
Key Trial Info
Start Date :
March 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04712214
Start Date
March 28 2021
End Date
October 30 2023
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College NHS Trust, Charing Cross Hospital
London, England, United Kingdom, W68RF